News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

TomoTherapy to Announce First Quarter Financial Results on Tuesday, May 3, 2011

4/15/2011 10:59:55 AM

MADISON, WI--(Marketwire - April 15, 2011) - TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, announced today that it will release its 2011 first quarter financial results on Tuesday, May 3, 2011 at 3:00 p.m. CDT.

TomoTherapy will hold an investment community conference call on Tuesday, May 3, 2011 beginning at 4:00 p.m. CDT. Fred Robertson, M.D., CEO, and Thomas Powell, CFO, will review first quarter performance. To join the conference call, dial 1-866-804-6927 (international 1-857-350-1673) and enter passcode 65695506. A replay of the conference call will be available at 7:00 p.m. CDT on May 3, 2011, through 10:59 p.m. CDT on May 10, 2011. To access the replay, dial 1-888-286-8010 (international 1-617-801-6888) and enter passcode 98537692.

For individual investors, a live Webcast of the conference call will be available on the Investor Relations page of Institutional investors can access the Webcast through a password-protected site, An archived Webcast of TomoTherapy's conference call will be available for two weeks.

About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions include its Hi-Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit

©2011 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi-Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

Investor Contact:
Thomas E. Powell
Chief Financial Officer
Email Contact

Media Contacts:
Kevin O'Malley
Director, Corporate Communications
Email Contact

Susan Lehman
Rockpoint Public Relations
Email Contact

Read at

comments powered by Disqus